Whole exome sequencing (WES) with in silico gene panel analysis
Clinical Report (Download a sample report here)
~3-6 weeks*
For detailed information about the sample requirements, please consult our clinical sample requirements page.
This is the expanded panel for Hypertrophic Cardiomyopathy (HCM). We also offer a core panel which includes 23 less genes (59 genes in total). See test details for the Hypertrophic Cardiomyopathy (HCM)- Core Panel.
Hypertrophic cardiomyopathy (HCM), is a disease that causes thickening (hypertrophy) of the heart muscle. The heart muscle cells enlarge more than they should, and scarring (fibrosis) often develops between the cells.
HCM is a genetically heterogeneous cardiac muscle disorder with a diverse natural history.
And important insights into the genetic landscape of HCM have enhanced understanding of the molecular pathogenesis, empowered gene-based diagnostic testing to identify at-risk individuals.